|PharmaStem Therapeutics, Inc. is the
pioneer in the development of umbilical cord and placental blood
preservation for therapeutic use.
company was founded in 1985 as Biocyte Corporation. Through
their dedicated research, Biocyte’s scientists were
able to prove for the first time that stem cells contained
in umbilical cord and placental blood could cure certain diseases
previously treatable only with bone marrow. The clinical success
of this research was highlighted by the first ever human transplant
of stem cells from umbilical cord blood, conducted in Paris
PharmaStem Therapeutics, Inc. is committed
to promoting research & development of new therapies using
umbilical cord and placental blood stem cells.